The primary HSC culture results suggested that the deletion of lincRNA-p21 expression was associated with promoter methylation, and these conditions implied the potential of serum lincRNA-p21 as a potential biomarker of liver fibrosis in patients with chronic hepatitis B/cirrhosis. The gene discussed is CDKN1A; the disease is chronic hepatitis B virus infection.